Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.353EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.353EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.407EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.123 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.71EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.12.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.51EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XREWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.67EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.277EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used